PLRX
Price
$11.21
Change
-$0.39 (-3.36%)
Updated
Jan 17 closing price
Capitalization
682.17M
45 days until earnings call
VYGR
Price
$5.07
Change
+$0.01 (+0.20%)
Updated
Jan 17 closing price
Capitalization
276.95M
52 days until earnings call
Ad is loading...

PLRX vs VYGR

Header iconPLRX vs VYGR Comparison
Open Charts PLRX vs VYGRBanner chart's image
Pliant Therapeutics
Price$11.21
Change-$0.39 (-3.36%)
Volume$672.62K
Capitalization682.17M
Voyager Therapeutics
Price$5.07
Change+$0.01 (+0.20%)
Volume$211.66K
Capitalization276.95M
PLRX vs VYGR Comparison Chart
Loading...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PLRX vs. VYGR commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PLRX is a Hold and VYGR is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (PLRX: $11.21 vs. VYGR: $5.07)
Brand notoriety: PLRX and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PLRX: 121% vs. VYGR: 46%
Market capitalization -- PLRX: $682.17M vs. VYGR: $276.95M
PLRX [@Biotechnology] is valued at $682.17M. VYGR’s [@Biotechnology] market capitalization is $276.95M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PLRX’s FA Score shows that 0 FA rating(s) are green whileVYGR’s FA Score has 1 green FA rating(s).

  • PLRX’s FA Score: 0 green, 5 red.
  • VYGR’s FA Score: 1 green, 4 red.
According to our system of comparison, VYGR is a better buy in the long-term than PLRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PLRX’s TA Score shows that 2 TA indicator(s) are bullish while VYGR’s TA Score has 4 bullish TA indicator(s).

  • PLRX’s TA Score: 2 bullish, 4 bearish.
  • VYGR’s TA Score: 4 bullish, 1 bearish.
According to our system of comparison, VYGR is a better buy in the short-term than PLRX.

Price Growth

PLRX (@Biotechnology) experienced а -6.66% price change this week, while VYGR (@Biotechnology) price change was -6.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

PLRX is expected to report earnings on May 12, 2025.

VYGR is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PLRX($682M) has a higher market cap than VYGR($277M). VYGR YTD gains are higher at: -10.582 vs. PLRX (-14.882). VYGR has higher annual earnings (EBITDA): 14.1M vs. PLRX (-197.04M). PLRX has more cash in the bank: 405M vs. VYGR (345M). VYGR has less debt than PLRX: VYGR (45.3M) vs PLRX (60.2M). VYGR has higher revenues than PLRX: VYGR (164M) vs PLRX (0).
PLRXVYGRPLRX / VYGR
Capitalization682M277M246%
EBITDA-197.04M14.1M-1,397%
Gain YTD-14.882-10.582141%
P/E RatioN/A7.68-
Revenue0164M-
Total Cash405M345M117%
Total Debt60.2M45.3M133%
FUNDAMENTALS RATINGS
VYGR: Fundamental Ratings
VYGR
OUTLOOK RATING
1..100
65
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
59
PRICE GROWTH RATING
1..100
92
P/E GROWTH RATING
1..100
30
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PLRXVYGR
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 11 days ago
88%
Bullish Trend 11 days ago
78%
Momentum
ODDS (%)
Bearish Trend 11 days ago
90%
Bullish Trend 11 days ago
85%
MACD
ODDS (%)
N/A
Bullish Trend 11 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 11 days ago
87%
Bullish Trend 11 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
88%
Bearish Trend 11 days ago
86%
Advances
ODDS (%)
Bullish Trend 16 days ago
77%
Bullish Trend 16 days ago
78%
Declines
ODDS (%)
Bearish Trend 20 days ago
87%
Bearish Trend 11 days ago
84%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 11 days ago
86%
N/A
View a ticker or compare two or three
Ad is loading...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PNRCX42.010.19
+0.45%
PGIM Jennison Natural Resources C
JVAAX38.310.15
+0.39%
JPMorgan Value Advantage A
DHFIX13.030.03
+0.23%
Diamond Hill Large Cap Concentrated I
PCOTX17.93N/A
N/A
Pioneer Core Equity C
SSMOX11.39N/A
N/A
Steward Values Enhanced SmMidCapR6

PLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLRX has been loosely correlated with RCKT. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if PLRX jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLRX
1D Price
Change %
PLRX100%
-3.36%
RCKT - PLRX
51%
Loosely correlated
+0.98%
NTLA - PLRX
51%
Loosely correlated
+0.85%
PRME - PLRX
50%
Loosely correlated
+0.70%
CRSP - PLRX
50%
Loosely correlated
+0.57%
BEAM - PLRX
49%
Loosely correlated
+0.17%
More